» COMPANY NEWS

Veterinary oncology market is profiled in new report from Brakke Consulting 10/16/2014

A new study from Brakke Consulting offers a look into the #1 killer of dogs and cats: cancer. 

”Oncology is one of the highest interest areas in veterinary medicine today,” said Lynn Fondon DVM, a senior consultant at Brakke Consulting.  “In the past 7 years, the US has gone from zero cancer therapies approved for veterinary use to a half-dozen, with at least a dozen more under development.”

The study, Cancer in Dogs and Cats, provides information on the incidence of cancer in pets, examines how cancer is diagnosed and treated in veterinary medicine, and offers estimated costs for treatment.  The report reviews the FDA-approved cancer treatments that are now on the market; new and developing veterinary cancer products, including therapies and diagnostics, are also presented in the report. 

“Our veterinary survey found that despite costs that can reach thousands of dollars, many dog and cat owners are willing to pursue treatment when their pets are diagnosed with cancer,” comments Dr. Fondon.

The report - the third edition of a study first fielded in 2002, and subsequently updated in 2009 - gathered information from a wide variety of sources, including published literature, specialist interviews, and a survey of 250 small animal veterinarians.

Cancer in Dogs and Cats is available from Brakke Consulting for $8,500. For more information, interested companies can visit the Brakke Consulting website at www.BrakkeConsulting.com.

About Brakke Consulting

Brakke Consulting, Inc.  specializes in the animal health and nutrition sectors. The company is known for providing strategic, timely information for the animal health industry through its syndicated market studies and custom research projects.

print version